Acute myeloid leukemia (AML) trials are testing combinations of targeted agents like venetoclax with hypomethylating agents, showing improved response rates in older adults. For acute lymphoblastic leukemia (ALL), bispecific antibodies and CAR-T cell therapy trials report high complete remission rates. Chronic lymphocytic leukemia (CLL) research focuses on BTK inhibitors and combination regimens that aim for deeper, longer-lasting responses. Minimal residual disease (MRD) testing in trials helps doctors determine if cancer cells are truly eliminated. These advances mean more treatment options than ever before, many accessible through clinical trials at specialized centers.
Cancer
How Effective Are New Leukemia Treatments?
Quick Answer
New leukemia treatments in clinical trials are showing promising results. CAR-T cell therapies have achieved complete remission rates above 80% in certain types of acute leukemia, and targeted therapies are extending survival for chronic leukemia patients.
Take the Next Step
Find clinical trials that match your condition, location, and treatment preferences.